BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34023185)

  • 41. Improving local control with breast-conserving therapy: a 27-year single-institution experience.
    Cabioglu N; Hunt KK; Buchholz TA; Mirza N; Singletary SE; Kuerer HM; Babiera GV; Ames FC; Sahin AA; Meric-Bernstam F
    Cancer; 2005 Jul; 104(1):20-9. PubMed ID: 15912514
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel 10-fraction breast irradiation in prone and supine position: technical, dosimetric and clinical evaluation.
    Guenzi M; Bosetti D; Lamanna G; Siffredi G; Bonzano E; Gusinu M; Garelli S; Pupillo F; Corvò R
    Tumori; 2015; 101(2):154-60. PubMed ID: 25838252
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Targeted Intraoperative Radiotherapy Tumour Bed Boost During Breast Conserving Surgery after Neoadjuvant Chemotherapy in HER2 Positive and Triple Negative Breast Cancer.
    Kolberg HC; Loevey G; Akpolat-Basci L; Stephanou M; Fasching PA; Untch M; Bulsara M; Vaidya JS; Liedtke C
    Rev Recent Clin Trials; 2017; 12(2):93-100. PubMed ID: 28155607
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adjuvant hypofractionated radiation therapy for breast cancer after conserving surgery.
    Livi L; Stefanacci M; Scoccianti S; Dicosmo D; Borghesi S; Nosi F; Simontacchi G; Mangoni M; Paiar F; Ponticelli P; Nori J; Chiavacci A; Biti GP
    Clin Oncol (R Coll Radiol); 2007 Mar; 19(2):120-4. PubMed ID: 17355107
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Radiotherapy versus low-dose tamoxifen following breast-conserving surgery for low-risk and estrogen receptor-positive breast ductal carcinoma in situ: an international open-label randomized non-inferiority trial (TBCC-ARO DCIS Trial).
    Kuo SH; Tseng LM; Chen ST; Sagara Y; Chang YC; Yeh HT; Kuo YL; Hung CC; Lu TP; Lee YH; Toi M; Huang CS
    BMC Cancer; 2023 Sep; 23(1):865. PubMed ID: 37710198
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analysis of Outcomes Using Hypofractionated Tumor Bed Boost Combined With Hypofractionated Whole Breast Irradiation for Early-stage Breast Cancer.
    Yu E; Huang D; Leonard K; Dipetrillo T; Wazer D; Hepel J
    Clin Breast Cancer; 2017 Dec; 17(8):638-643. PubMed ID: 28629952
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The impact of dose heterogeneity on late normal tissue complication risk after hypofractionated whole breast radiotherapy.
    Tsang Y; Haviland J; Venables K; Yarnold J;
    Radiother Oncol; 2012 Aug; 104(2):143-7. PubMed ID: 22809586
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial.
    Kunkler IH; Williams LJ; Jack WJ; Cameron DA; Dixon JM;
    Lancet Oncol; 2015 Mar; 16(3):266-73. PubMed ID: 25637340
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Local-regional control of recurrent breast carcinoma after mastectomy: does hyperfractionated accelerated radiotherapy improve local control?
    Ballo MT; Strom EA; Prost H; Singletary SE; Theriault RL; Buchholz TA; McNeese MD
    Int J Radiat Oncol Biol Phys; 1999 Apr; 44(1):105-12. PubMed ID: 10219802
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of pathological characteristics on local relapse after breast-conserving therapy: a subgroup analysis of the EORTC boost versus no boost trial.
    Jones HA; Antonini N; Hart AA; Peterse JL; Horiot JC; Collin F; Poortmans PM; Oei SB; Collette L; Struikmans H; Van den Bogaert WF; Fourquet A; Jager JJ; Schinagl DA; Wárlám-Rodenhuis CC; Bartelink H
    J Clin Oncol; 2009 Oct; 27(30):4939-47. PubMed ID: 19720914
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Accelerated whole breast irradiation in early breast cancer patients with adverse prognostic features.
    Lee SW; Shin KH; Chie EK; Kim JH; Im SA; Han W; Noh DY; Lim HW; Kim TH; Lee KS; Lee ES; Sung SY; Kim K
    Oncotarget; 2016 Dec; 7(49):81888-81898. PubMed ID: 27588485
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hypofractionated irradiation in elderly patients with breast cancer after breast conserving surgery and mastectomy : Analysis of 205 cases.
    Doré M; Cutuli B; Cellier P; Campion L; Le Blanc M
    Radiat Oncol; 2015 Aug; 10():161. PubMed ID: 26238442
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Accelerated partial breast irradiation with interstitial brachytherapy as second conservative treatment for ipsilateral breast tumour recurrence: multicentric study of the GEC-ESTRO Breast Cancer Working Group.
    Hannoun-Levi JM; Resch A; Gal J; Kauer-Dorner D; Strnad V; Niehoff P; Loessl K; Kovács G; Van Limbergen E; Polgár C;
    Radiother Oncol; 2013 Aug; 108(2):226-31. PubMed ID: 23647758
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intraoperative radiotherapy (IORT) for breast cancer using the Intrabeam system.
    Kraus-Tiefenbacher U; Scheda A; Steil V; Hermann B; Kehrer T; Bauer L; Melchert F; Wenz F
    Tumori; 2005; 91(4):339-45. PubMed ID: 16277101
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of two radiation boost schedules in postlumpectomy patients with breast cancer.
    Yadav BS; Sharma SC; Singh G; Dahiya D
    J Cancer Res Ther; 2020; 16(6):1344-1349. PubMed ID: 33342794
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The impact of age on the risk of ipsilateral breast tumor recurrence after breast-conserving therapy in breast cancer patients with a > 5 mm margin treated without boost irradiation.
    Ono Y; Yoshimura M; Hirata K; Yamauchi C; Toi M; Suzuki E; Takada M; Hiraoka M; Mizowaki T
    Radiat Oncol; 2019 Jul; 14(1):121. PubMed ID: 31291997
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer.
    Touboul E; Buffat L; Belkacémi Y; Lefranc JP; Uzan S; Lhuillier P; Faivre C; Huart J; Lotz JP; Antoine M; Pène F; Blondon J; Izrael V; Laugier A; Schlienger M; Housset M
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):25-38. PubMed ID: 9989511
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ten-year results of accelerated hypofractionated adjuvant whole-breast radiation with concomitant boost to the lumpectomy cavity after conserving surgery for early breast cancer.
    Cante D; Petrucci E; Sciacero P; Piva C; Ferrario S; Bagnera S; Patania S; Mondini G; Pasquino M; Casanova Borca V; Vellani G; La Porta MR; Franco P
    Med Oncol; 2017 Sep; 34(9):152. PubMed ID: 28776318
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Implementation of 26 Gy in five fractions over 1 week adjuvant radiotherapy for breast cancer: Prospective report of acute skin toxicity and consideration of resource implications.
    Nugent K; Quinlan E; Cleary S; O'Driscoll H; Rohan C; Trousdell J; Williams J; Dunne M; McArdle O; Duane FK
    Breast; 2023 Feb; 67():55-61. PubMed ID: 36603414
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Local relapse in young (< or = 40 years) women with breast cancer after mastectomy or breast conserving surgery: 15-year results].
    Fodor J; Mózsa E; Zaka Z; Polgár C; Major T
    Magy Onkol; 2005; 49(3):203, 205-8. PubMed ID: 16249814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.